Highlights

[DPHARMA] YoY Annual (Unaudited) Result on 2012-12-31 [#4]

Stock [DPHARMA]: DUOPHARMA BIOTECH BHD
Announcement Date 25-Feb-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2012
Quarter 31-Dec-2012  [#4]
Profit Trend YoY -     -2.59%
Quarter Report


View:


Show?  YoY % Horiz. %

Annual (Unaudited) Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 270,680 176,961 162,405 135,310 138,132 131,437 123,766 13.92%
  YoY % 52.96% 8.96% 20.02% -2.04% 5.09% 6.20% -
  Horiz. % 218.70% 142.98% 131.22% 109.33% 111.61% 106.20% 100.00%
PBT 49,755 46,509 40,175 35,298 34,728 35,408 38,215 4.49%
  YoY % 6.98% 15.77% 13.82% 1.64% -1.92% -7.35% -
  Horiz. % 130.20% 121.70% 105.13% 92.37% 90.88% 92.65% 100.00%
Tax 0 0 -7,900 -9,284 -8,023 -6,739 -7,982 -
  YoY % 0.00% 0.00% 14.91% -15.72% -19.05% 15.57% -
  Horiz. % -0.00% -0.00% 98.97% 116.31% 100.51% 84.43% 100.00%
NP 49,755 46,509 32,275 26,014 26,705 28,669 30,233 8.65%
  YoY % 6.98% 44.10% 24.07% -2.59% -6.85% -5.17% -
  Horiz. % 164.57% 153.84% 106.75% 86.05% 88.33% 94.83% 100.00%
NP to SH 38,775 35,271 32,275 26,014 26,705 28,669 30,233 4.23%
  YoY % 9.93% 9.28% 24.07% -2.59% -6.85% -5.17% -
  Horiz. % 128.25% 116.66% 106.75% 86.05% 88.33% 94.83% 100.00%
Tax Rate - % - % 19.66 % 26.30 % 23.10 % 19.03 % 20.89 % -
  YoY % 0.00% 0.00% -25.25% 13.85% 21.39% -8.90% -
  Horiz. % 0.00% 0.00% 94.11% 125.90% 110.58% 91.10% 100.00%
Total Cost 220,925 130,452 130,130 109,296 111,427 102,768 93,533 15.39%
  YoY % 69.35% 0.25% 19.06% -1.91% 8.43% 9.87% -
  Horiz. % 236.20% 139.47% 139.13% 116.85% 119.13% 109.87% 100.00%
Net Worth 270,177 192,942 181,850 169,354 163,783 156,881 142,975 11.18%
  YoY % 40.03% 6.10% 7.38% 3.40% 4.40% 9.73% -
  Horiz. % 188.97% 134.95% 127.19% 118.45% 114.55% 109.73% 100.00%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 15,843 25,679 24,293 19,434 24,983 222 24,985 -7.31%
  YoY % -38.30% 5.71% 25.00% -22.21% 11,147.32% -99.11% -
  Horiz. % 63.41% 102.78% 97.23% 77.78% 99.99% 0.89% 100.00%
Div Payout % 40.86 % 72.81 % 75.27 % 74.71 % 93.56 % 0.77 % 82.64 % -11.07%
  YoY % -43.88% -3.27% 0.75% -20.15% 12,050.65% -99.07% -
  Horiz. % 49.44% 88.11% 91.08% 90.40% 113.21% 0.93% 100.00%
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 270,177 192,942 181,850 169,354 163,783 156,881 142,975 11.18%
  YoY % 40.03% 6.10% 7.38% 3.40% 4.40% 9.73% -
  Horiz. % 188.97% 134.95% 127.19% 118.45% 114.55% 109.73% 100.00%
NOSH 166,776 138,807 138,817 138,815 138,799 138,832 138,810 3.10%
  YoY % 20.15% -0.01% 0.00% 0.01% -0.02% 0.02% -
  Horiz. % 120.15% 100.00% 100.00% 100.00% 99.99% 100.02% 100.00%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 18.38 % 26.28 % 19.87 % 19.23 % 19.33 % 21.81 % 24.43 % -4.63%
  YoY % -30.06% 32.26% 3.33% -0.52% -11.37% -10.72% -
  Horiz. % 75.24% 107.57% 81.33% 78.71% 79.12% 89.28% 100.00%
ROE 14.35 % 18.28 % 17.75 % 15.36 % 16.31 % 18.27 % 21.15 % -6.26%
  YoY % -21.50% 2.99% 15.56% -5.82% -10.73% -13.62% -
  Horiz. % 67.85% 86.43% 83.92% 72.62% 77.12% 86.38% 100.00%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 162.30 127.49 116.99 97.47 99.52 94.67 89.16 10.49%
  YoY % 27.30% 8.98% 20.03% -2.06% 5.12% 6.18% -
  Horiz. % 182.03% 142.99% 131.21% 109.32% 111.62% 106.18% 100.00%
EPS 19.17 25.41 23.25 18.74 19.24 20.65 21.78 -2.10%
  YoY % -24.56% 9.29% 24.07% -2.60% -6.83% -5.19% -
  Horiz. % 88.02% 116.67% 106.75% 86.04% 88.34% 94.81% 100.00%
DPS 9.50 18.50 17.50 14.00 18.00 0.16 18.00 -10.10%
  YoY % -48.65% 5.71% 25.00% -22.22% 11,150.00% -99.11% -
  Horiz. % 52.78% 102.78% 97.22% 77.78% 100.00% 0.89% 100.00%
NAPS 1.6200 1.3900 1.3100 1.2200 1.1800 1.1300 1.0300 7.84%
  YoY % 16.55% 6.11% 7.38% 3.39% 4.42% 9.71% -
  Horiz. % 157.28% 134.95% 127.18% 118.45% 114.56% 109.71% 100.00%
Adjusted Per Share Value based on latest NOSH - 941,773
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 28.74 18.79 17.24 14.37 14.67 13.96 13.14 13.93%
  YoY % 52.95% 8.99% 19.97% -2.04% 5.09% 6.24% -
  Horiz. % 218.72% 143.00% 131.20% 109.36% 111.64% 106.24% 100.00%
EPS 4.12 3.75 3.43 2.76 2.84 3.04 3.21 4.25%
  YoY % 9.87% 9.33% 24.28% -2.82% -6.58% -5.30% -
  Horiz. % 128.35% 116.82% 106.85% 85.98% 88.47% 94.70% 100.00%
DPS 1.68 2.73 2.58 2.06 2.65 0.02 2.65 -7.31%
  YoY % -38.46% 5.81% 25.24% -22.26% 13,150.00% -99.25% -
  Horiz. % 63.40% 103.02% 97.36% 77.74% 100.00% 0.75% 100.00%
NAPS 0.2869 0.2049 0.1931 0.1798 0.1739 0.1666 0.1518 11.19%
  YoY % 40.02% 6.11% 7.40% 3.39% 4.38% 9.75% -
  Horiz. % 189.00% 134.98% 127.21% 118.45% 114.56% 109.75% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 2.6200 2.5000 2.5800 2.1300 2.0200 2.3900 2.4000 -
P/RPS 1.61 1.96 2.21 2.19 2.03 2.52 2.69 -8.20%
  YoY % -17.86% -11.31% 0.91% 7.88% -19.44% -6.32% -
  Horiz. % 59.85% 72.86% 82.16% 81.41% 75.46% 93.68% 100.00%
P/EPS 11.27 9.84 11.10 11.37 10.50 11.57 11.02 0.37%
  YoY % 14.53% -11.35% -2.37% 8.29% -9.25% 4.99% -
  Horiz. % 102.27% 89.29% 100.73% 103.18% 95.28% 104.99% 100.00%
EY 8.87 10.16 9.01 8.80 9.52 8.64 9.08 -0.39%
  YoY % -12.70% 12.76% 2.39% -7.56% 10.19% -4.85% -
  Horiz. % 97.69% 111.89% 99.23% 96.92% 104.85% 95.15% 100.00%
DY 3.63 7.40 6.78 6.57 8.91 0.07 7.50 -11.39%
  YoY % -50.95% 9.14% 3.20% -26.26% 12,628.57% -99.07% -
  Horiz. % 48.40% 98.67% 90.40% 87.60% 118.80% 0.93% 100.00%
P/NAPS 1.62 1.80 1.97 1.75 1.71 2.12 2.33 -5.87%
  YoY % -10.00% -8.63% 12.57% 2.34% -19.34% -9.01% -
  Horiz. % 69.53% 77.25% 84.55% 75.11% 73.39% 90.99% 100.00%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 23/02/16 24/02/15 26/02/14 25/02/13 22/02/12 23/02/11 23/02/10 -
Price 2.6100 2.9200 2.6000 2.1700 2.1200 2.4500 2.3300 -
P/RPS 1.61 2.29 2.22 2.23 2.13 2.59 2.61 -7.73%
  YoY % -29.69% 3.15% -0.45% 4.69% -17.76% -0.77% -
  Horiz. % 61.69% 87.74% 85.06% 85.44% 81.61% 99.23% 100.00%
P/EPS 11.23 11.49 11.18 11.58 11.02 11.86 10.70 0.81%
  YoY % -2.26% 2.77% -3.45% 5.08% -7.08% 10.84% -
  Horiz. % 104.95% 107.38% 104.49% 108.22% 102.99% 110.84% 100.00%
EY 8.91 8.70 8.94 8.64 9.08 8.43 9.35 -0.80%
  YoY % 2.41% -2.68% 3.47% -4.85% 7.71% -9.84% -
  Horiz. % 95.29% 93.05% 95.61% 92.41% 97.11% 90.16% 100.00%
DY 3.64 6.34 6.73 6.45 8.49 0.07 7.73 -11.79%
  YoY % -42.59% -5.79% 4.34% -24.03% 12,028.57% -99.09% -
  Horiz. % 47.09% 82.02% 87.06% 83.44% 109.83% 0.91% 100.00%
P/NAPS 1.61 2.10 1.98 1.78 1.80 2.17 2.26 -5.49%
  YoY % -23.33% 6.06% 11.24% -1.11% -17.05% -3.98% -
  Horiz. % 71.24% 92.92% 87.61% 78.76% 79.65% 96.02% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


TOP ARTICLES

1. THE MOST UNDERVALUED TECH STOCK ON BURSA MALAYSIA NOW Art of Investments
2. Hiap Teck’s big player depressing the price - Koon Yew Yin Koon Yew Yin's Blog
3. PublicInvest Research Headlines - 24 Sept 2021 PublicInvest Research
4. Top Glove: 4 management concerns that caught my attention over the past year - Shak Chee Hoi Good Articles to Share
5. KPOWER, SOLARVEST, SAMAIDEN & PEKAT: Compare & Contrast their Prices, Earnings & Price to Book Value, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
6. PALM OIL WILL BE A BRIGHT SHINING STAR AS VERY HIGH PROFIT-GROWTH PHASE IS NOW ON-GOING, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
7. Mplus Market Pulse - 24 Sept 2021 M+ Online Research Articles
8. MCA: 51% bumi equity for freight forwarders against country's goals of creating pro-business environment save malaysia!
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

396  502  563  848 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 PASUKGB 0.06-0.005 
 DNEX 0.81-0.02 
 KAB 0.41+0.015 
 VS-WB 0.58+0.04 
 MINETEC-PR 0.005+0.005 
 SAPNRG 0.1150.00 
 KAB-WA 0.055+0.005 
 TANCO 0.26+0.015 
 VS 1.70+0.18 
 HSI-HG8 0.49+0.07 
PARTNERS & BROKERS